PDCD1 and cancer: In the case of S-PD-1, a higher percentage of patients with early stage cancer had higher levels (frequency score of 2, 22%) of S-PD-1 than for advanced disease patients (frequency score of 2, 2%) (P = 0.033) (Additional file 4: Table S2).